Increased expression of the KRAS oncogene is identified in 22–43% of endometrial carcinomas [8] and leads to changes in the expression of ATR and CHEK1 genes, key components of the ATR-CHEK1-WEE1 signaling pathway responsible for DNA replication and repair. This evidence concerns the gene CHEK1 and endometrial carcinoma.